A detailed history of Westbourne Investment Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Westbourne Investment Advisors, Inc. holds 8,521 shares of MRK stock, worth $845,112. This represents 0.34% of its overall portfolio holdings.

Number of Shares
8,521
Previous 8,425 1.14%
Holding current value
$845,112
Previous $1.04 Million 7.19%
% of portfolio
0.34%
Previous 0.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$111.15 - $128.97 $10,670 - $12,381
96 Added 1.14%
8,521 $968,000
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $5,662 - $6,597
-50 Reduced 0.59%
8,425 $1.11 Million
Q4 2023

Jan 17, 2024

BUY
$100.18 - $109.02 $25,946 - $28,236
259 Added 3.15%
8,475 $924,000
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $12,924 - $14,087
-119 Reduced 1.43%
8,216 $948,000
Q1 2023

Apr 24, 2023

SELL
$102.94 - $114.86 $56,617 - $63,173
-550 Reduced 6.19%
8,335 $887,000
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $61,208 - $78,477
-700 Reduced 7.3%
8,885 $986,000
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $67,624 - $75,968
800 Added 9.11%
9,585 $825,000
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $2,087 - $2,366
-25 Reduced 0.28%
8,785 $801,000
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $636,786 - $797,657
8,810 New
8,810 $675,000
Q3 2021

Oct 25, 2021

SELL
$71.68 - $78.83 $189,593 - $208,505
-2,645 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$70.31 - $77.77 $29,178 - $32,274
-415 Reduced 13.56%
2,645 $206,000
Q1 2021

Apr 27, 2021

BUY
$68.86 - $81.11 $210,711 - $248,196
3,060 New
3,060 $236,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Westbourne Investment Advisors, Inc. Portfolio

Follow Westbourne Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.